isocarboxazid has been researched along with Metabolism, Inborn Errors in 2 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Metabolism, Inborn Errors: Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watts, RW | 1 |
| Chalmers, RA | 1 |
| Gibbs, DA | 1 |
| Lawson, AM | 1 |
| Purkiss, P | 1 |
| Spellacy, E | 1 |
| Bourke, E | 1 |
| Frindt, G | 1 |
| Flynn, P | 1 |
| Schreiner, GE | 1 |
2 other studies available for isocarboxazid and Metabolism, Inborn Errors
| Article | Year |
|---|---|
Studies on some possible biochemical treatments of primary hyperoxaluria.
Topics: Adolescent; Adult; Animals; Child; Cholestyramine Resin; Female; Haplorhini; Humans; Isocarboxazid; | 1979 |
Primary hyperoxaluria with normal alpha-ketoglutarate: glyoxylate carboligase activity. Treatment with isocarboxazid.
Topics: Allopurinol; Child; Female; Glycolates; Glyoxylates; Humans; Isocarboxazid; Ketoglutaric Acids; Kidn | 1972 |